Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Phillips, AN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 169 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Babiker, A; Darbyshire, N; Pezzotti, P; Porter, K; Rezza, G; Walker, S; Beral, V; Coutinho, R; Del Amo, J; Gill, N; Lee, C; Meyer, L; Tyrer, F; Dabis, F; Thiebaut, R; Lawson-Ayayi, S; Meyer, L; Boufassa, F; Hamouda, O; Lorenzo, JI; Touloumi, G; Hatzakis, A; Karafoulidou, A; Katsarou, O; Brettle, R; del Romero, J; Prins, M; Coutinho, RA; van Benthem, B; Coutinho, RA; Kirk, O; Pedersen, C; Aguado, IH; Perez-Hoyos, S; Eskild, A; Bruun, JN; Sannes, M; Sabin, C; Johnson, AM; Phillips, AN; Darbyshire, JH; Francioli, P; Vanhems, P; Egger, M; Rickenbach, M; Cooper, D; Kaldor, J; Vizzard, J; Tusell, JM; Ruiz, I; Cayla, JA; de Olalla, PG; Day, NE; De Angelis, D
      Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Moore, AL; Mocroft, A; Madge, S; Devereux, H; Wilson, D; Phillips, AN; Johnson, M
      Gender differences in virologic response to treatment in an HIV-positive population: A cohort study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Sabin, CA; Phillips, AN
      Cohort studies in sexual health

      SEXUALLY TRANSMITTED INFECTIONS
    4. Sabin, CA; Phillips, AN
      Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies

      Journal of antimicrobial chemotherapy
    5. Lepri, AC; Phillips, AN; Monforte, AD; Castelli, F; Antinori, A; de Luca, A; Pezzotti, P; Alberici, F; Cargnel, A; Grima, P; Piscopo, R; Prestileo, T; Scalise, G; Vigevani, M; Moroni, M
      When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

      AIDS
    6. Kirk, O; Mocroft, A; Pradier, C; Bruun, JN; Hemmer, R; Clotet, B; Miller, V; Viard, JP; Phillips, AN; Lundgren, JD
      Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir

      AIDS
    7. Mocroft, A; Youle, M; Moore, A; Sabin, CA; Madge, S; Lepri, AC; Tyrer, M; Chaloner, C; Wilson, D; Loveday, C; Johnson, MA; Phillips, AN
      Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre

      AIDS
    8. Mocroft, A; Phillips, AN; Miller, V; Gatell, J; van Lunzen, J; Parkin, JM; Weber, R; Roge, B; Lazzarin, A; Lundgren, JD
      The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

      AIDS
    9. Moore, AL; Vashisht, A; Sabin, CA; Mocroft, A; Madge, S; Phillips, AN; Studd, JWW; Johnson, MA
      Reduced bone mineral density in HIV-positive individuals

      AIDS
    10. Lepri, AC; Miller, V; Phillips, AN; Rabenau, H; Sabin, CA; Staszewski, S
      The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load

      AIDS
    11. Phillips, AN; Staszewski, S; Weber, R; Kirk, O; Francioli, P; Miller, V; Vernazza, P; Lundgren, JD; Ledergerber, B
      HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    12. Perno, CF; Cozzi-Lepri, A; Balotta, C; Forbici, F; Violin, M; Bertoli, A; Facchi, G; Pezzotti, P; Cadeo, G; Tositti, G; Pasquinucci, S; Pauluzzi, S; Scalzini, A; Salassa, B; Vincenti, A; Phillips, AN; Dianzani, F; Appice, A; Angarano, G; Monno, L; Ippolito, G; Moroni, M; Monforte, AD
      Secondary mutations in the protease region of human immunodeficiency virusand virologic failure in drug-naive patients treated with protease inhibitor-based therapy

      JOURNAL OF INFECTIOUS DISEASES
    13. Sabin, CA; Lepri, AC; Devereux, H; Phillips, AN; Loveday, C; Lee, CA
      Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia

      JOURNAL OF INFECTIOUS DISEASES
    14. Smith, GD; Phillips, AN
      Re: "Cigarette smoking and suicide: A prospective study of 300,000 male active-duty army soldiers"

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    15. Rezza, G; Lepri, AC; Monforte, AD; Pezzotti, P; Castelli, F; Dianzani, F; Lazzarin, A; De Luca, A; Arlotti, M; Leoncini, F; Manconi, PE; Rizzardini, G; Minoli, L; Poggio, A; Ippolito, G; Phillips, AN; Moroni, M
      Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Mocroft, A; Gill, MJ; Davidson, W; Phillips, AN
      Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Sabin, CA; Devereux, H; Phillips, AN; Hill, A; Janossy, G; Lee, CA; Loveday, C
      Course of viral load throughout HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Kirk, O; Gatell, JM; Mocroft, A; Pedersen, C; Proenca, R; Brettle, RP; Barton, SE; Sudre, P; Phillips, AN; Lundgren, JD
      Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviraltherapy

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    19. Sabin, CA; Yee, TT; Devereux, H; Griffioen, A; Loveday, C; Phillips, AN; Lee, CA
      Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy

      AIDS
    20. Monforte, AD; Lepri, AC; Rezza, G; Pezzotti, P; Antinori, A; Phillips, AN; Angarano, G; Colangeli, V; De Luca, A; Ippolito, G; Caggese, L; Soscia, F; Filice, G; Gritti, F; Narciso, P; Tirelli, U; Moroni, M
      Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients

      AIDS
    21. Miller, V; Sabin, CA; Phillips, AN; Rottmann, C; Rabenau, H; Weidmann, E; Rickerts, V; Findhammer, S; Helm, EB; Staszewski, S
      The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

      AIDS
    22. Porter, K; Babiker, A; Walker, S; Darbyshire, J; Gill, N; Beral, V; Coutinho, R; Darbyshire, J; Gill, N; Lee, C; Meyer, L; Rezza, G; Porter, K; Babiker, A; Walker, S; Darbyshire, J; Tyrer, F; Dabis, F; Marimoutou, C; Meyer, L; Boufassa, F; Hamouda, O; Brunn, M; Pezzotti, P; Rezza, G; Lorenzo, JI; Touloumi, G; Hatzakis, A; Karafoulidou, A; Katsarou, O; Brettle, R; Del Amo, J; del Romero, J; Prins, M; Coutinho, RA; van Benthem, B; Coutinho, RA; Kirk, O; Pedersen, C; AGuado, IH; Perez-Hoyos, S; Eskild, A; Bruun, JN; Sannes, M; Sabin, C; Lee, C; Johnson, AM; Phillips, AN; Babiker, A; Darbyshire, JH; Gill, N; Porter, K; Egger, M; Francioli, P; Rickenbach, M; Cooper, D; Kaldor, J; Cooper, D; Kaldor, J; Vizzard, J; Tusell, JM; Ruiz, I; Cayla, JA; de Olalla, PG; Day, NE; De Angelis, D
      Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE

      AIDS
    23. Youle, M; Janossy, G; Turnbull, W; Tilling, R; Loveday, C; Mocroft, A; Tyrer, M; Madge, S; Wilson, D; Dykhoff, A; Johnson, M; Phillips, AN
      Changes in CD4 lymphocyte counts after interruption of therapy in patientswith viral failure on protease inhibitor-containing regimens

      AIDS
    24. Mocroft, A; Devereux, H; Kinloch-de-Loes, S; Wilson, D; Madge, S; Youle, M; Tyrer, M; Loveday, C; Phillips, AN; Johnson, MA
      Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population

      AIDS
    25. Mocroft, A; Katlama, C; Johnson, AM; Pradier, C; Antunes, F; Mulcahy, F; Chiesi, A; Phillips, AN; Kirk, O; Lundgren, JD
      AIDS across Europe, 1994-98: the EuroSIDA study

      LANCET
    26. Ullum, H; Lepri, AC; Katzenstein, TL; Phillips, AN; Skinhoj, P; Gerstoft, J; Pedersen, BK
      Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin a in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    27. Marang-van de Mheen, PJ; Smith, GD; Hart, CL; Hole, DJ; Phillips, AN
      The influence of gender, social circumstances and smoking on survival: theRenfrew and Paisley study

      PUBLIC HEALTH
    28. Vanhems, P; Hirschel, B; Phillips, AN; Cooper, DA; Vizzard, J; Brassard, J; Perrin, L
      Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS

      JOURNAL OF INFECTIOUS DISEASES
    29. Sabin, CA; Devereux, HL; Clewley, G; Emery, VC; Phillips, AN; Loveday, C; Lee, CA; Griffiths, PD
      Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNAlevels in individuals with hemophilia

      JOURNAL OF INFECTIOUS DISEASES
    30. Mocroft, A; Sabin, CA; Youle, M; Madge, S; Tyrer, M; Devereux, H; Deayton, J; Dykhoff, A; Lipman, MCI; Phillips, AN; Johnson, MA
      Changes in AIDS-defining illnesses in a London clinic, 1987-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    31. Stephenson, JM; Griffioen, A; Woronowski, H; Phillips, AN; Petruckevitch, A; Keenlyside, R; Johnson, AM; Anderson, J; Melville, R; Jeffries, DJ; Norman, J; Barton, S; Chard, S; Sibley, K; Mitchelmore, M; Brettle, R; Morris, S; O'Dornen, P; Russell, J; Overington-Hickford, L; O'Farrell, N; Chappell, J; Mulcahy, RF; Moseley, J; Lyons, F; Welch, J; Graham, D; Fadojutimi, M; Kitchen, V; Wells, C; Byrne, G; Tobin, J; Tucker, L; Harindra, V; Mercey, DE; Allason-jones, E; Campbell, L; French, R; Johnson, MA; Reid, A; Farmer, D; Saint, N; Olaitan, A; Madge, S; Forster, G; Phillips, M; Sampson, K; Nayagam, A; Edlin, J; Bradbeer, C; de Ruiter, A; Hargreaves, L; Doyle, C
      Survival and progression of HIV disease in women attending GUM/HIV clinicsin Britain and Ireland

      SEXUALLY TRANSMITTED INFECTIONS
    32. Del Amo, J; Petruckevitch, A; Phillips, AN; De Cock, KM; Stephenson, J; Desmond, N; Hanscheid, T; Low, N; Newell, A; Obasi, A; Paine, K; Pym, A; Theodore, C; Johnson, AM
      Risk factors for tuberculosis in patients with AIDS in London: a case-control study

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    33. Petruckevitch, A; Del Amo, J; Phillips, AN; Stephenson, JM; Johnson, AM; De Cock, KM
      Risk of cancer in patients with HIV disease

      INTERNATIONAL JOURNAL OF STD & AIDS
    34. Aladdin, H; Ullum, H; Lepri, AC; Leffers, H; Katzenstein, T; Gerstoft, J; Gjedde, SB; Phillips, AN; Skinhoj, P; Pedersen, BK
      Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    35. Ullum, H; Lepri, AC; Aladdin, H; Katzenstein, T; Victor, J; Phillips, AN; Gerstoft, J; Skinhoj, P; Pedersen, BK
      Natural immunity and HIV disease progression

      AIDS
    36. Mocroft, A; Sabin, C; Phillips, AN
      Impact of Kaposi's sarcoma on HIV disease progression

      AIDS
    37. Chiesi, A; Mocroft, A; Dally, LG; Miller, V; Katlama, C; Ledergerber, B; Pedersen, C; Phillips, AN; Arcieri, R; Lundgren, JD
      Regional survival differences across Europe in HIV-positive people: the EuroSIDA study

      AIDS
    38. Phillips, AN; Grabar, S; Tassie, JM; Costagliola, D; Lundgren, JD; Egger, M
      Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials

      AIDS
    39. Porter, K; Johnson, AM; Phillips, AN; Darbyshire, JH
      The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK Register of HIV Seroconverters

      AIDS
    40. Babiker, A; Darbyshire, JH; Gill, ON; Johnson, AM; Phillips, AN; Porter, K; Beral, V; Brettle, R; Carne, C; Gilson, RJC; Goldberg, D; Hawkins, DA; Jeffries, D; Johnson, MA; McMichael, AJ; Mortimer, PP; Pozniak, A; Weber, J; Wellsteed, S
      How soon after HIV seroconversion is antiretroviral therapy initiated?

      AIDS
    41. Mocroft, A; Barry, S; Sabin, CA; Lepri, AC; Kinloch, S; Drinkwater, A; Lipman, M; Youle, M; Johnson, MA; Phillips, AN
      The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997

      AIDS
    42. Phillips, AN; McLean, AR; Loveday, C; Tyrer, M; Bofill, M; Devereux, H; Madge, S; Dykoff, A; Drinkwater, A; Burke, A; Huckett, L; Janossy, G; Johnson, MA
      In vivo HIV-1 replicative capacity in early and advanced infection

      AIDS
    43. Taggart, PJ; Locke, T; Phillips, AN; Pask, N; Hollomon, DW; Kendall, SJ; Cooke, LR; Mercer, PC
      Benzimidazole resistance in Rhynchosporium secalis and its effect on barley leaf blotch control in the UK

      CROP PROTECTION
    44. Griffiths, PD; Ait-Khaled, M; Bearcroft, CP; Clark, DA; Quaglia, A; Davies, SE; Burroughs, AK; Rolles, K; Kidd, IM; Knight, SN; Noibi, SM; Cope, AV; Phillips, AN; Emery, VC
      Human herpesviruses 6 and 7 as potential pathogens after liver transplant:Prospective comparison with the effect of cytomegalovirus

      JOURNAL OF MEDICAL VIROLOGY
    45. Emery, VC; Atkins, MC; Bowen, EF; Clark, DA; Johnson, MA; Kidd, IM; McLaughlin, JE; Phillips, AN; Strappe, PM; Griffiths, PD
      Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: Evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6

      JOURNAL OF MEDICAL VIROLOGY
    46. Weverling, GJ; Mocroft, A; Ledergerber, B; Kirk, O; Gonzalez-Lahoz, J; Monforte, AD; Proenca, R; Phillips, AN; Lundgren, JD; Reiss, P
      Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection

      LANCET
    47. Miller, V; Staszewski, S; Nisius, G; Lepri, AC; Sabin, C; Phillips, AN
      Risk of new AIDS diseases in people on triple therapy

      LANCET
    48. Miller, V; Staszewski, S; Sabin, C; Carlebach, A; Rottmann, C; Weidmann, E; Rabenau, H; Hill, A; Lepri, AC; Phillips, AN
      CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load

      JOURNAL OF INFECTIOUS DISEASES
    49. Miller, V; Mocroft, A; Reiss, P; Katlama, C; Papadopoulos, AI; Katzenstein, T; van Lunzen, J; Antunes, F; Phillips, AN; Lundgren, JD
      Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study

      ANNALS OF INTERNAL MEDICINE
    50. PHILLIPS AN; KATLAMA C; BARTON S; VELLA S; BLAXHULT A; CLOTET B; GOEBEL FD; HIRSCHEL B; PEDERSEN C; LUNDGREN JD
      SURVIVAL IN 2367-ZIDOVUDINE-TREATED PATIENTS ACCORDING TO USE OF OTHER NUCLEOSIDE ANALOG DRUGS

      Journal of acquired immune deficiency syndromes and human retrovirology
    51. SABIN CA; MOCROFT A; LEPRI AC; PHILLIPS AN
      COFACTORS AND MARKERS OF DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Journal of the Royal Statistical Society. Series A. Statistics in society
    52. LEPRI AC; SABIN CA; PHILLIPS AN; LEE CA; PEZZOTTI P; REZZA G
      THE RATE OF CD4 DECLINE AS A DETERMINANT OF PROGRESSION TO AIDS INDEPENDENT OF THE MOST RECENT CD4 COUNT

      Epidemiology and infection
    53. WANNAMETHEE SG; SIRIVICHAYAKUL S; PHILLIPS AN; UBOLYAM S; RUXRUNGTHAM K; HANVANICH M; PHANUPHAK P
      CLINICAL AND IMMUNOLOGICAL FEATURES OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN PATIENTS FROM BANGKOK, THAILAND

      International journal of epidemiology
    54. Madge, S; Phillips, AN; Griffioen, A; Olaitan, A; Johnson, MA
      Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland

      INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
    55. PETRUCKEVITCH A; DELAMO J; PHILLIPS AN; JOHNSON AM; STEPHENSON J; DESMOND N; HANSCHEID T; LOW N; NEWELL A; OBASI A; PAINE K; PYM A; THEODORE C; DECOCK KM
      DISEASE PROGRESSION AND SURVIVAL FOLLOWING SPECIFIC AIDS-DEFINING CONDITIONS - A RETROSPECTIVE COHORT STUDY OF 2048 HIV-INFECTED PERSONS INLONDON

      AIDS
    56. EWART DW; DARBY SC; LEE CA; GIANGRANDE PFL; SPOONER RJD; PHILLIPS AN; LUDLAM CA
      IMMUNE STATUS IN HIV-1-INFECTED MEN AND BOYS WITH HEMOPHILIA IN THE UNITED-KINGDOM

      AIDS
    57. BERAL V; BABIKER A; BRETTLE R; CARNE C; DARBYSHIRE JH; EVANS BG; GILL ON; GILSON RJC; GOLDBERG D; HAWKINS DA; JEFFRIES D; JOHNSON AM; JOHNSON MA; MCMICHAEL AJ; MORTIMER PP; PHILLIPS AN; PORTER K; POZNIAK A; WEBER J; WELLSTEED S
      THE AIDS INCUBATION PERIOD IN THE UK ESTIMATED FROM A NATIONAL REGISTER OF HIV SEROCONVERTERS

      AIDS
    58. STASZEWSKI S; MILLER V; SABIN C; BERGER A; HILL AM; PHILLIPS AN
      REBOUND OF HIV-1 VIRAL LOAD AFTER SUPPRESSION TO VERY-LOW LEVELS

      AIDS
    59. MOCROFT A; GILL MJ; DAVIDSON W; PHILLIPS AN
      PREDICTORS OF A VIRAL RESPONSE AND SUBSEQUENT VIROLOGICAL TREATMENT FAILURE IN PATIENTS WITH HIV STARTING A PROTEASE INHIBITOR

      AIDS
    60. PHILLIPS AN; LOVEDAY C; JOHNSON MA
      HIV SUPPRESSION AND RISK OF DRUG-RESISTANCE MUTATIONS

      AIDS
    61. LEPRI AC; KATZENSTEIN TL; ULLUM H; PHILLIPS AN; SKINHOJ P; GERSTOFT J; PEDERSEN BK
      THE RELATIVE PROGNOSTIC VALUE OF PLASMA HIV RNA LEVELS AND CD4 LYMPHOCYTE COUNTS IN ADVANCED HIV-INFECTION

      AIDS
    62. SABIN CA; DEVEREUX H; PHILLIPS AN; JANOSSY G; LOVEDAY C; LEE CA
      IMMUNE MARKERS AND VIRAL LOAD AFTER HIV-1 SEROCONVERSION AS PREDICTORS OF DISEASE PROGRESSION IN A COHORT OF HEMOPHILIC MEN

      AIDS
    63. LEPRI AC; PHILLIPS AN; PEZZOTTI P; MOCROFT A; SABIN CA; PORTER K; REZZA G
      EVALUATING THE EFFECT OF YEAR OF SEROCONVERSION ON HIV PROGRESSION INCOHORT STUDIES

      AIDS
    64. LEPRI AC; SMITH GD; MOCROFT A; SABIN CA; MORRIS RW; PHILLIPS AN
      A PRACTICAL APPROACH TO ADJUSTING FOR ATTRITION BIAS IN HIV CLINICAL-TRIALS WITH SERIAL MARKER RESPONSES

      AIDS
    65. MOCROFT A; VELLA S; BENFIELD TL; CHIESI A; MILLER V; GARGALIANOS P; MONFORTE AD; YUST I; BRUUN JN; PHILLIPS AN; LUNDGREN JD
      CHANGING PATTERNS OF MORTALITY ACROSS EUROPE IN PATIENTS INFECTED WITH HIV-1

      Lancet
    66. PHILLIPS AN
      CYTOTOXIC-T-CELL RESPONSES IN EARLY HIV-1 INFECTION

      The New England journal of medicine
    67. SABIN CA; MOCROFT A; BOFILL M; JANOSSY G; LEE CA; JOHNSON M; PHILLIPS AN
      CHANGES IN LYMPHOCYTE SUBSETS IN HUMAN-IMMUNODEFICIENCY-VIRUS-POSITIVE PERSONS WITH LESS-THAN-5 CD4 T-LYMPHOCYTES MM(3)/

      The Journal of infectious diseases
    68. ULLUM H; LEPRI AC; VICTOR J; ALADDIN H; PHILLIPS AN; GERSTOFT J; SKINHOJ P; PEDERSEN BK
      PRODUCTION OF BETA-CHEMOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION - EVIDENCE THAT HIGH-LEVELS OF MACROPHAGE IN INFLAMMATORY PROTEIN-1-BETA ARE ASSOCIATED WITH A DECREASED RISK OF HIV DISEASE PROGRESSION

      The Journal of infectious diseases
    69. WILDE JT; LEE CA; DARBY SC; EWART DW; GIANGRANDE PLF; LUDLAM CA; PHILLIPS AN; SPOONER RJD; WINTER M
      THE INCIDENCE OF LYMPHOMA IN THE UK HEMOPHILIA POPULATION OVER A 20-YEAR PERIOD

      British Journal of Haematology
    70. MOCROFT A; YOULE M; PHILLIPS AN; HALAI R; EASTERBROOK P; JOHNSON MA; GAZZARD B
      THE INCIDENCE OF AIDS-DEFINING ILLNESSES IN 4883 PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Archives of internal medicine
    71. SABIN CA; BOFILL M; PHILLIPS AN; ELFORD J; JANOSSY G; LEE CA
      RELATION BETWEEN SOLUBLE CD30 LEVELS MEASURED SOON AFTER HIV SEROCONVERSION AND DISEASE PROGRESSION IN MEN WITH HEMOPHILIA

      Journal of acquired immune deficiency syndromes and human retrovirology
    72. LUNDGREN JD; PHILLIPS AN; VELLA S; KATLAMA C; LEDERGERBER B; JOHNSON AM; REISS P; GATELL J; CLUMECK N; DIETRICH M; BENFIELD TL; NIELSEN JO; PEDERSEN C
      REGIONAL DIFFERENCES IN USE OF ANTIRETROVIRAL AGENTS AND PRIMARY PROPHYLAXIS IN 3122 EUROPEAN HIV-INFECTED PATIENTS

      Journal of acquired immune deficiency syndromes and human retrovirology
    73. PHILLIPS AN; MOCROFT A; SABIN CA; LEPRI AC
      CROSS-SECTIONAL STUDIES IN AIDS PATHOGENESIS - HOW FAR CAN THEY MISLEAD US

      Journal of acquired immune deficiency syndromes and human retrovirology
    74. SMITH GD; EGGER M; PHILLIPS AN
      METAANALYSIS - BEYOND THE GRAND MEAN

      BMJ. British medical journal
    75. EGGER M; SMITH GD; PHILLIPS AN
      METAANALYSIS - PRINCIPLES AND PROCEDURES

      BMJ. British medical journal
    76. LEPRI AC; PHILLIPS AN; PEZZOTTI P; REZZA G
      IS THE CLINICAL COURSE OF HIV-INFECTION CHANGING - STUDYS CENSORING STRATEGY MAY BE SOURCE OF BIAS

      BMJ. British medical journal
    77. SMITH GD; PHILLIPS AN
      INTERSALT DATA - CORRECTION FOR REGRESSION DILUTION BIAS IN INTERSALTSTUDY WAS MISLEADING

      BMJ. British medical journal
    78. MOCROFT A; YOULE M; MORCINEK J; SABIN CA; GAZZARD B; JOHNSON MA; PHILLIPS AN
      SURVIVAL AFTER DIAGNOSIS OF AIDS - A PROSPECTIVE OBSERVATIONAL STUDY OF 2625 PATIENTS

      BMJ. British medical journal
    79. MOCROFT A; JOHNSON MA; SABIN CA; BOFILL M; JANOSSY G; PHILLIPS AN
      THE RELATIONSHIP BETWEEN BETA-2-MICROGLOBULIN, CD4 LYMPHOCYTE COUNT, AIDS AND DEATH IN HIV-POSITIVE INDIVIDUALS

      Epidemiology and infection
    80. ULLUM H; LEPRI AC; BENDTZEN K; VICTOR J; GOTZSCHE PC; PHILLIPS AN; SKINHOJ P; PEDERSEN BK
      LOW PRODUCTION OF INTERFERON-GAMMA IS RELATED TO DISEASE PROGRESSION IN HIV-INFECTION - EVIDENCE FROM A COHORT OF 347 HIV-INFECTED INDIVIDUALS

      AIDS research and human retroviruses
    81. MOCROFT AJ; LUNDGREN JD; MONFORTE AD; LEDERGERBER B; BARTON SE; VELLA S; KATLAMA C; GERSTOFT J; PEDERSEN C; PHILLIPS AN
      SURVIVAL OF AIDS PATIENTS ACCORDING TO TYPE OF AIDS-DEFINING EVENT

      International journal of epidemiology
    82. SABIN CA; MOCROFT A; BOFILL M; JANOSSY G; JOHNSON M; LEE CA; PHILLIPS AN
      SURVIVAL AFTER A VERY-LOW (LESS-THAN-5X10(6) L) CD4+ T-CELL COUNT IN INDIVIDUALS INFECTED WITH HIV/

      AIDS
    83. DORRUCCI M; PEZZOTTI P; PHILLIPS AN; ALLIEGRO MB; REZZA G; BOROS S; LEPRI AC; SINICCO A; ANGARANO G; TARANTINI G; SALASSA B; CASTELLI F; PRISTERA R; GAFA S; COLANGELI V; VIALE P; BARBANERA M; ZACCARELLI M; CANESSA A; ORTONA L; LAZZARIN A; TIRELLI U; AIUTI F
      ANTIRETROVIRAL TREATMENT AND PROGRESSION TO AIDS IN HIV SEROCONVERTERS FROM DIFFERENT RISK GROUPS

      AIDS
    84. PHILLIPS AN; ERON J; BARTLETT J; KURITZKES DR; JOHNSON VA; GILBERT C; JOHNSON J; KELLER A; HILL AM; AKIL B; BEALL G; BELLOS N; BERRY P; BRUMMIT C; CAMERON B; COHEN C; DONABEDIAN H; MAYAR K; MCKINLEY G; SEPULVEDA G; THOMPSON M; TSOUKAS C; WALMSLEY S; HORTON J; KERKERING T; MATTHEW E; PEARCE D; PETERSON D; POTTAGE J; SAMPSON J; SMITH W; YANGCO B; COWAN J; KACZKA C; ZAMECK R; DAWSON D; POBINER B; SCOTTLENNOX J; DEMASI R; JARRETT P; YUEN G; ESINHART J; QUINN J; FALLON MA; BENOIT S
      CORRESPONDENCE BETWEEN THE EFFECT OF ZIDOVUDINE PLUS LAMIVUDINE ON PLASMA HIV LEVEL CD4 LYMPHOCYTE COUNT AND THE INCIDENCE OF CLINICAL-DISEASE IN INFECTED INDIVIDUALS

      AIDS
    85. LEPRI AC; SABIN CA; PHILLIPS AN
      INVESTIGATING TEMPORAL CHANGES IN THE RATE OF HIV PROGRESSION - CHALLENGES AND LIMITATIONS

      AIDS
    86. ULLUM H; LEPRI AC; VICTOR J; SKINHOJ P; PHILLIPS AN; PEDERSEN BK
      INCREASED LOSSES OF CD4-INFECTION IS RELATED TO INCREASED RISK OF DEATH - EVIDENCE FROM A COHORT OF 347 HIV-INFECTED INDIVIDUALS(CD45RA+ CELLS IN LATE STAGES OF HIV)

      AIDS
    87. MUNOZ A; SABIN CA; PHILLIPS AN
      THE INCUBATION PERIOD OF AIDS

      AIDS
    88. PHILLIPS AN; MCLEAN A; JOHNSON MA; TYRER M; EMERY V; GRIFFITHS P; BOFILL M; JANOSSY G; LOVEDAY C
      HIV-1 DYNAMICS AFTER TRANSIENT ANTIRETROVIRAL THERAPY - IMPLICATIONS FOR PATHOGENESIS AND CLINICAL MANAGEMENT

      Journal of medical virology
    89. BROWN AJL; LOBIDEL D; WADE CM; REBUS S; PHILLIPS AN; BRETTLE RP; FRANCE AJ; LEEN CS; MCMENAMIN J; MCMILLAN A; MAW RD; MULCAHY F; ROBERTSON JR; SANKAR KN; SCOTT G; WYLD R; PEUTHERER JF
      THE MOLECULAR EPIDEMIOLOGY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN 6 CITIES IN BRITAIN AND IRELAND

      Virology
    90. PHILLIPS AN; SMITH GD
      VIRAL LOAD AND COMBINATION THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS

      The New England journal of medicine
    91. SABIN CA; TELFER P; PHILLIPS AN; BHAGANI S; LEE CA
      HEPATITIS-C VIRUS-INFECTION IN A HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE COHORT IN HAWAII - REPLY

      The Journal of infectious diseases
    92. LEPRI AC; SABIN CA; PEZZOTTI P; ENGLAND PD; PHILLIPS AN; REZZA G
      IS THERE A GENERAL TENDENCY FOR CD4 LYMPHOCYTE DECLINE TO SPEED-UP DURING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - EVIDENCE FROM THE ITALIAN SEROCONVERSION STUDY

      The Journal of infectious diseases
    93. SABIN CA; TELFER P; PHILLIPS AN; BHAGANI S; LEE CA
      THE ASSOCIATION BETWEEN HEPATITIS-C VIRUS GENOTYPE AND HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE PROGRESSION IN A COHORT OF HEMOPHILIC MEN

      The Journal of infectious diseases
    94. ALLIEGRO MB; DORRUCCI M; PHILLIPS AN; PEZZOTTI P; BOROS S; ZACCARELLI M; PRISTERA R; REZZA G; LEPRI AC; SINICCO A; TARANTINI G; ANGARANO G; BUCCOLIERO G; LAZZARIN A; AIUTI F; SALASSA B; CASTELLI F; VIALE P; MAZZARELLO G; BARBANERA M; COLANGELI V; ORTONA L; URSITTI MA; TIRELLI U
      INCIDENCE AND CONSEQUENCES OF PREGNANCY IN WOMEN WITH KNOWN DURATION OF HIV-INFECTION

      Archives of internal medicine
    95. ALCABES P; PEZZOTTI P; PHILLIPS AN; REZZA G; VLAHOV D
      LONG-TERM PERSPECTIVE ON THE PREVALENT-COHORT BIASES IN STUDIES OF HUMAN-IMMUNODEFICIENCY-VIRUS PROGRESSION

      American journal of epidemiology
    96. SABIN CA; PASI J; PHILLIPS AN; LILLEY P; ELFORD J; LEE CA
      THE USE OF INTERMEDIATE-PURITY CLOTTING FACTOR CONCENTRATES AND HIV DISEASE PROGRESSION IN MEN WITH HEMOPHILIA

      Haemophilia
    97. PHILLIPS AN; SABIN CA; ELFORD J; BOFILL M; TIMMS A; JANOSSY G; LEE CA
      SERUM BETA(2)-MICROGLOBULIN AT HIV-1 SEROCONVERSION AS A PREDICTOR OFSEVERE IMMUNODEFICIENCY DURING 10 YEARS OF FOLLOW-UP

      Journal of acquired immune deficiency syndromes and human retrovirology
    98. LUNDGREN JD; PHILLIPS AN
      FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA - REPLY

      Clinical infectious diseases
    99. PHILLIPS AN; WANNAMETHEE SG; WALKER M; THOMSON A; SMITH GD
      LIFE EXPECTANCY IN MEN WHO HAVE NEVER SMOKED AND THOSE WHO HAVE SMOKED CONTINUOUSLY - 15-YEAR FOLLOW-UP OF LARGE COHORT OF MIDDLE-AGED BRITISH MEN

      BMJ. British medical journal
    100. SMITH GD; PHILLIPS AN
      PASSIVE SMOKING AND HEALTH - SHOULD WE BELIEVE PHILIP-MORRIS EXPERTS

      BMJ. British medical journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 22:39:59